Lebovits Chaim's Form 4/A amendment
AmendedBrainstorm Cell Therapeutics Inc. (BCLI) · filed Jul 31, 2024
- Accession no.
- 0001104659-24-084339
- Filed
- Jul 31, 2024, 4:07 PM ET
- Trade date
- May 7, 2024
- Filing delay
- 85 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 7, 2024
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $24.8K. It was filed 85 days after the trade.
This amendment replaces 0001104659-24-058218 (filed May 7, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lebovits ChaimCIK 0001406302 | Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | Common Stock | PPurchaseAcquired | +66,300 | $0.3743 | +$24,816.09 | 1,059,865 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.